Introduction
============

During metazoan development, NOTCH signaling is involved in a multitude of cell fate decisions, especially when single cells are selected from a group of equivalent precursor cells ([@b22]; [@b6]). Well-studied examples include *Drosophila* wing formation, mammalian angiogenesis ([@b44]), or neuronal fate decisions ([@b34]; [@b1]). Moreover, the NOTCH pathway is deregulated in different types of human cancer ([@b56]; [@b52]). The binding of a DSL (Delta/Serrate/LAG-2) family NOTCH ligand activates two specific proteolytic cleavage events that result in the release of the NOTCH intracellular domain (NICD) from the plasma membrane ([@b5]). NICD then enters the nucleus, where it interacts with CSL (CBF1, Suppressor of Hairless, LAG-1) family transcription factors to induce the expression of target genes. Therefore, NOTCH signaling is often used as a cell fate switch that can be rapidly turned on. However, since NOTCH signaling also needs to be turned off at specific time points, the turnover of NICD in the nucleus is a critical aspect of NOTCH signaling. Experiments with mammalian cells have shown that NICD phosphorylation and/or deacetylation targets it for degradation ([@b29]; [@b32]). Furthermore, the F-box and WD repeat containing protein SEL-10/Fbw7 inhibits NOTCH signaling by inducing ubiquitination leading to proteasomal degradation of NICD ([@b36]; [@b33]). However, the specific mechanisms regulating NICD stability are largely unknown.

The development of the *Caenorhabditis elegans* hermaphrodite vulva is one of the best-studied systems to investigate the molecular mechanisms governing cell fate determination during organogenesis ([@b55]). NOTCH signaling has a prominent role in this process ([@b31]; [@b57]). During vulval induction, an organizer cell in the somatic gonad, called anchor cell (AC), induces the adjacent VPC P6.p the primary (1°) vulval cell fate by activating the epidermal growth factor receptor (EGFR) signaling pathway ([Figure 1A](#f1){ref-type="fig"}). As a consequence of adopting the 1° fate, P6.p expresses the DSL ligands that activate lateral LIN-12 NOTCH signaling in the neighboring VPCs P5.p and P7.p. NOTCH signaling in P5.p and P7.p prevents these cells from adopting the 1° fate and induces the alternate secondary (2°) fate (blue arrows in [Figure 1A](#f1){ref-type="fig"}). On the other hand, EGFR/RAS/MAPK signaling in P6.p inhibits NOTCH signaling by promoting the endocytosis and subsequent lysosomal degradation of LIN-12 NOTCH, thus allowing P6.p to irreversibly adopt the 1° cell fate ([@b53]). The precise timing of the activation and inactivation of the EGFR/RAS/MAPK and NOTCH signaling pathways is essential to achieve a robust cell fate pattern during vulval development ([@b21]; [@b4]; [@b53]; [@b26]). One important question is therefore to identify the molecular mechanisms that link these signaling pathways to the temporal regulation of vulval development.

Computational models are excellent tools to describe and systematically analyze the dynamic behavior of a biological system and generate new hypotheses that can be tested experimentally ([@b39]; [@b24]). To this aim, we have previously developed a state-based computational model incorporating the current mechanistic understanding of gene interactions during *C. elegans* vulval development ([@b27]). State-based models are particularly suitable for building mechanistic models of such well-studied biological systems, as they do not require quantitative data relating to the number of molecules or reaction rates. One characteristic feature of our model was the inclusion of multiple modes of crosstalk between the EGFR/RAS/MAPK and LIN-12 NOTCH signaling pathways ([@b7]; [@b26]). Our computational model defines the behavior of biological objects (i.e., the VPCs) over time, based on the various states that an object can enter over its lifetime. *Interacting* state machines specify causal relationships between state changes in different objects to describe how objects communicate and collaborate. Usually, the state of an object is determined by the states of its parts such as the genes or proteins regulating the process of interest. Each part has its own reaction to the states of other parts. Changes in the state of an object are thus determined by the interdependent state changes of all parts. A hierarchical structure allows one to view a system at different levels of detail. State-based models have previously been used to model a variety of processes such as T-cell activation and differentiation in the thymus ([@b37]; [@b19], [@b20]), or pancreatic development ([@b51]).

In this study, we tested through an iterative process of computational modeling, prediction, and experimentation whether cell-cycle progression could provide a mechanism that coordinates the temporal activities of the different signaling pathways involved in VPC fate specification. Although the VPCs progress through the cell cycle in a largely cell-autonomous manner, global synchronization mechanisms imposed by the heterochronic genes that regulate cell-cycle checkpoints may prevent the VPCs from progressing in an uncoordinated manner ([@b21]; [@b60]). To test this idea, we arrested cell-cycle progression in individual VPCs to 'de-synchronize\' them. As predicted by our computational model based on *bounded asynchrony* ([@b25]), this perturbation prevented VPCs from adopting a stable cell fate. Moreover, we found a synchronization mechanism acting on the NOTCH signaling pathway. In particular, the termination of the NOTCH signal is tightly coupled to cell-cycle progression, as the degradation of NICD occurs only after entry into the G2 phase. Thus, the formation of a stable cell fate pattern during vulval development involves a strict temporal control of NOTCH signaling during cell-cycle progression.

Results
=======

A state-based model for VPC differentiation based on bounded asynchrony
-----------------------------------------------------------------------

Our previous models of *C. elegans* vulval development used high-level abstractions and described the biological process with an interacting state machine ([@b27], [@b26]). These models were constructed by defining the behavior of sub-components and then letting them work in parallel. In our initial model, there were six identical sub-components, each representing one VPC. There are two standard notions of such parallel composition: synchronous composition and asynchronous composition. Using synchronous composition, all sub-components perform actions together exactly at the same time. When we tried to model the VPC interactions, we found that a synchronous composition was too rigid, making it impossible to break the symmetry within the VPC equivalence group without introducing additional mechanisms for breaking symmetry. Indeed, as the VPCs are equipotent, they all proceeded in exactly the same way and it was only possible to differentiate them if they experienced differences in their environment. For example, in the case of mutants displaying an alternating 1° and 2° fate pattern, a model with a perfectly synchronous progression resulted in all VPCs adopting the 1° cell fate. On the other hand, using an asynchronous composition, where every sub-component performs actions independently, it was possible to differentiate the VPCs. However, some VPCs adopted a 1° instead of a 2° fate because they did not sense the progress of their neighbors and proceeded much faster than others. A completely asynchronous model of VPC differentiation therefore resulted in a variable and unpredictable pattern of cell fates due to excess 'noise\' in the temporal progression of the VPCs. To limit the degree of asynchrony between the VPCs, we introduced the concept of *bounded asynchrony*, a notion of concurrency tailored to the modeling of biological cell--cell interactions ([@b25]). *Bounded asynchrony* is achieved via a scheduler that limits the number of steps that one VPC is allowed to get ahead of the others. This allows the components of a system to move independently, while keeping them coupled to a certain degree. The constrained non-deterministic nature of a model incorporating *bounded asynchrony* captures the variability observed in cells that, although equipotent, assume distinct fates. Although a scheduler may be an artificial mechanism, it does highlight the need to precisely coordinate the timing of different events between the VPCs. Hence, we searched for a distributed computational mechanism that can keep the VPCs together for a long time and requires infrequent global synchronizations. Such a mechanism seems plausible since global synchronization mechanisms do exist in many biological systems including VPC differentiation ([@b21]). Here, we used timed automata to build such a mechanism ([@b3]). The general principle of timed automata is illustrated in [Figure 1B](#f1){ref-type="fig"}. Abstractly, each timed automaton represents a VPC that takes approximately *t* time units to perform an action ([Figure 1C](#f1){ref-type="fig"}). We therefore allowed the timed automaton to perform the action between times *t*−1 and *t*+1. Depending on the value of *t*, the system can perform approximately *t* rounds (i.e., every cell *t* actions), allowing each cell to perform at the maximum one more action than the other cells. A simulation composed of four such timed automata, where each automaton moves after ∼10 time units, is shown in [Figure 1D](#f1){ref-type="fig"}. In this exemplary simulation, up to time point 120 the difference in number of steps between cells (Δ*x*) does not exceed 1. At time point 120, 'cell\' a3 (green line) has taken 12 steps, while 'cell\' a4 (violet line) has only taken 10 steps (Δ*x*=2). The mechanism ensures that Δ*x*=1 up to time point 99, after which the potential difference increases gradually. If an additional mechanism synchronizes these automata every 100 time units, then the difference Δ*x* will continue to be restricted to 1 indefinitely. Thus, a model that combines approximate time keeping together with global synchronization might be an appropriate way to represent the variability that is inherent to all cellular systems.

VPCs enter M phase in a random order
------------------------------------

One feature of *bounded asynchrony* is the fact that the sub-components may enter the next state in an arbitrary order. If VPC differentiation was to be governed by a mechanism resembling *bounded asynchrony*, then the VPCs should indeed progress through the cell cycle in a slightly asynchronous manner. To address this question, we examined the order in which the VPCs enter the M phase of the cell cycle. For this purpose, we observed the divisions of the proximal VPCs P5.p, P6.p, and P7.p in wild-type larvae using Nomarski optics and scored the time of entry into prometaphase based on nuclear envelope breakdown ([Figure 1E](#f1){ref-type="fig"}). Among the three proximal VPCs, we observed no bias in the order at which they entered M phase, as each of the three VPCs was equally likely to divide first. Using time-lapse imaging, we measured the temporal differences in VPC divisions. The average time span between the first and last proximal VPC divisions was 33.4 min with a maximum divergence of 71 min (*n*=6). These results indicate that the VPCs adopting 1° and 2° cell fates do indeed enter the M phase in a random order, suggesting that the cell cycle of the VPCs progresses in a slightly asynchronous and unbiased manner.

Cell-cycle arrest interferes with VPC fate specification
--------------------------------------------------------

We next tested the biological significance of the computational concept of *bounded asynchrony* by manipulating the cell cycle in single VPCs. We hypothesized that, although the VPCs progress with slightly variable speed through the cell cycle, external mechanisms may keep them 'more or less\' synchronized and thereby align the relative timing of the signal transduction events between the VPCs. Under this assumption, the repeated use of cell-cycle checkpoints may represent such a synchronization mechanism. The VPCs are born during the first larval stage and remain in the G1 phase until the transition from the second to the third larval stage ([@b21]). During the second larval stage, 1° cell fate markers can be detected in P6.p, but the other five VPCs remain uncommitted ([@b4]). After the G1/S-phase arrest has been relieved, P5.p and P7.p adopt the 2° fate during the G2 phase, while the 3°, uninduced fate of the distal VPCs (P3.p, P4.p, and P8.p) is only sealed after these cells have divided and fused with the surrounding hypodermis (hyp7).

We therefore performed an experiment to specifically arrest the cell cycle in P6.p without affecting the progression of the other VPCs. For this purpose, we expressed the cyclin-dependent kinase (CDK) inhibitor *cki-1* under control of the 1° fate-specific *egl-17* promoter (*egl-17p::cki-1*) to arrest P6.p in the G1 phase without affecting cell-cycle progression in the other VPCs ([@b35]). We then observed the effect of this intervention on the VPC fate specification using 1° and 2° cell fate markers. As a readout for the 1° cell fate, we used a transcriptional *gfp* reporter of the RAS/MAP kinase target *egl-17* ([@b11]), and for the 2° fate, we observed a reporter of the LIN-12 NOTCH target *lip-1* ([@b7]).

In *egl-17p::cki-1* animals, in which P6.p was arrested and P5.p and P7.p had progressed to the Pn.px or Pn.pxx stage, expression of the 2° fate marker *lip-1p::gfp* persisted in the undivided P6.p cells at levels that were significantly higher than those detected in control animals ([Figure 2A](#f2){ref-type="fig"}). To rule out the possibility that the differences in *lip-1p::gfp* levels between arrested and non-arrested cells are due to a dilution of the GFP signal during the cell divisions, we corrected the signal intensities for the total nuclear areas. Even with this correction, we detected a significant difference in total *lip-1p::gfp* signal intensity between arrested P6.p and non-arrested P6.p descendants ([Supplementary Figure S1](#S1){ref-type="supplementary-material"}). Furthermore, expression of the 1° fate marker *egl-17p::gfp* in arrested P6.p cells was not affected ([Supplementary Figure S2](#S1){ref-type="supplementary-material"}), confirming the previous observation that 1° fate specification begins already during the G1 phase ([@b4]). However, our results also indicate that G1-arrested P6.p cells could not establish a fate-specific gene expression pattern, as they simultaneously expressed 1° and 2° cell fate markers. We conclude that a coordinated cell-cycle progression of the VPCs is necessary for the specification of a stable cell fate as judged by the expression of cell-fate markers.

Termination of NOTCH signaling is linked to cell-cycle progression
------------------------------------------------------------------

The finding that G1-arrested P6.p cells continued to express the 2° cell fate marker suggested that G1 cell-cycle arrest in P6.p might block the proper termination of LIN-12 NOTCH signaling. To investigate this possibility, we examined the expression of a functional, translational LIN-12::GFP reporter that reflects the expression pattern and sub-cellular localization of the endogenous LIN-12 protein ([@b43]; [@b53]). Before vulval induction, LIN-12::GFP is expressed at low levels in all VPCs. Most of the LIN-12 protein is localized to the apical plasma membrane of the VPCs. After vulval induction, LIN-12 is upregulated in the 2° P5.p and P7.p lineages and downregulated in the 1° P6.p lineage.

In control animals lacking the *egl-17p::cki-1* transgene, LIN-12::GFP was absent from the 1° P6.p descendants at the Pn.px stage, because LIN-12 NOTCH undergoes rapid endocytosis and degradation in the 1° lineage ([@b53]). In contrast, in *egl-17p::cki-1* transgenic animals at the Pn.px stage, in which P6.p had remained undivided, we detected elevated levels of LIN-12::GFP in the cytoplasm and nucleus of P6.p ([Figure 2B](#f2){ref-type="fig"}). However, the LIN-12::GFP signal was lost from the apical plasma membrane, indicating that the endocytosis of the full-length LIN-12 protein in P6.p is not affected by G1 arrest. Since the GFP tag in LIN-12::GFP is inserted in the intracellular domain (NICD) that is cleaved off the transmembrane domain during LIN-12 NOTCH activation, the persisting cytoplasmic and nuclear GFP signal in G1-arrested P6.p cells suggested that the downregulation of the cleaved, intracellular LIN-12 NICD occurs only after exit from the G1 phase. In this way, the termination of the LIN-12 NOTCH signal in the 1° lineage might be coupled to cell-cycle progression.

Degradation of NICD is blocked in G1-arrested VPCs
--------------------------------------------------

To directly test the connection between lateral signaling, NICD degradation, and the cell cycle, we integrated via the MosSCI technique ([@b28]) a single copy of an *nicd::gfp* transgene expressed under control of a *bar-1* promoter fragment into the genome at a specific site on chromosome II (*zhIs39\[nicd::gfp\]*). Importantly, the *bar-1* promoter fragment used drives uniform expression in the six VPCs and their descendants until the Pn.pxx stage ([@b49]; Figure 6A). Thanks to the single copy integration, we achieved a stable and reproducible NICD::GFP expression in the VPCs. The increased dosage of NOTCH signaling caused by *nicd::gfp* resulted in the ectopic induction of the 2° fate in P3.p, P4.p and P8.p and a Multivulva phenotype in all of the animals examined ([Table I](#t1){ref-type="table"}, row 1; [Supplementary Figure S3](#S1){ref-type="supplementary-material"}). However, P6.p in *nicd::gfp* animals still adopted the 1° fate as determined by its cell lineage (see insets in [Supplementary Figure S3](#S1){ref-type="supplementary-material"}). Moreover, the proximal VPCs in *nicd::gfp* animals entered M phase in a random order similar to the wild type ([Figure 1E](#f1){ref-type="fig"}).

We next performed a time-course analysis to follow NICD::GFP degradation in the induced VPCs and their descendants ([Figure 3A and B](#f3){ref-type="fig"}). NICD::GFP was uniformly expressed in the VPCs of early L2 larvae (+24 h relative to hatching, see Materials and methods). Interestingly, NICD::GFP expression first increased until the mid L2 stage (+27 h) and then started to decline in all VPCs. A significant difference between the 1° and 2° VPCs could first be detected at +32 h, shortly before the first VPCs started dividing ([Figure 3A](#f3){ref-type="fig"}). After this time point, NICD::GFP expression rapidly faded in P6.p. At the Pn.px stage, NICD::GFP was barely detectable in the 1° P6.p descendants, while expression persisted in the 2° P5.p and P7.p descendants, though at lower levels when compared with Pn.p stage animals (right panel in [Figure 3B](#f3){ref-type="fig"}). By the Pn.pxx stage, NICD::GFP was undetectable in P6.p descendants and further reduced in P5.p and P.7.p descendants. Similarly to full-length LIN-12::GFP, NICD::GFP in *egl-17p::cki-1* animals persisted in the nuclei of the arrested P6.p cells ([Figure 3C](#f3){ref-type="fig"}). Thus, NICD::GFP is progressively degraded in the induced VPCs and their descendants. Though, the rate of NICD degradation is significantly higher in the 1° than in the 2° lineage and depends on cell-cycle progression.

A computational model of VPC fate specification based on the cell cycle
-----------------------------------------------------------------------

Based on the experimental evidence, which indicated a linkage of VPC fate specification to cell-cycle progression, we incorporated the cell cycle as a key timing factor in our revised computational model. To implement *bounded asynchrony* in our refined computational model, we used an independent scheduler that recreates the same interactions between cells by limiting the number of steps one process gets ahead of the other as exhibited by the timed automata model described earlier. In our previous VPC models, an artificial delay in LIN-12 NOTCH downregulation was necessary to reproduce the proper behavior of *lin-12* and predict the correct fate patterns in lateral signaling mutants ([@b26]). With the introduction of the cell cycle, we removed this artificial delay and coupled the inhibition of LIN-12 to the state of the cell-cycle phases G1, S, or G2 (see [Supplementary information](#S1){ref-type="supplementary-material"} for a detailed description of the computational model). In a first *in silico* experiment, we allowed for the inhibition of lateral LIN-12 signaling to happen during the G1 phase. However, this configuration of the model failed to reproduce published experimental data. We further tested a model where inhibition of LIN-12 Notch was forbidden in the G1 phase but allowed during the S or G2 phase. This model was consistent with published experimental results (checked using model checking, see [Supplementary Table 2](#S1){ref-type="supplementary-material"}). Furthermore, the coupling between cell-cycle progression and LIN-12 NOTCH degradation was implemented in all VPCs in an identical manner (see [Supplementary Figure S17](#S1){ref-type="supplementary-material"}). However, when executing the model we found that LIN-12 levels in VPCs progressing toward a 1° fate stabilized at lower levels than in VPCs adopting a 2° fate. Taken together, the notion of *bounded asynchrony* introduced into our computational model through the cell cycle predicted that a temporal delay in the termination of the LIN-12 NOTCH signal after G1 is critical for the formation of a stable cell fate pattern.

NICD degradation occurs during the G2 phase
-------------------------------------------

To further narrow down the time window, during which NICD is degraded, we arrested the VPCs in the S phase by hydroxyurea treatment ([@b4]). Expression of the 2° cell fate reporter *lip-1p::yfp* persisted in the arrested P6.p cells and increased in the adjacent P5.p and P7.p cells ([Figure 4A](#f4){ref-type="fig"}). Overall, *lip-1p::yfp* reached significantly higher levels in S phase-arrested VPCs compared with the VPCs of untreated control animals. Accordingly, the degradation of NICD::GFP in P6.p was blocked in hydroxyurea-treated animals ([Figure 4B](#f4){ref-type="fig"}).

We then arrested the VPCs in the late G2 phase by RNAi-mediated knockdown of *cdk-1*, which is essential for the G2-to-M phase progression ([@b48]; [@b8]). Since the *cdk-1* RNAi phenotype is incompletely penetrant, this procedure resulted in the random arrest of single or multiple VPCs per affected animal. Similarly to hydroxyurea-treated animals, the undivided VPCs in *cdk-1* RNAi animals expressed elevated levels of NICD::GFP, and the bias in P6.p versus P5.p and P7.p-specific expression was lost in the G2-arrested VPCs ([Figure 4C](#f4){ref-type="fig"}). Taken together, the cell-cycle arrest and time-course experiments indicate that NICD is degraded in the VPCs either during the late G2 phase or at the time of entry into the M phase. The persisting expression of NICD::GFP in VPCs arrested by *cdk-1* RNAi may also indicate a direct involvement of a CDK-1/Cyclin complex in NICD degradation (see below).

The G1 cyclins CYE-1 and CYD-1 promote while the G2 cyclin CYB-3 inhibits NOTCH activity
----------------------------------------------------------------------------------------

To investigate which CDK/Cyclin complexes are responsible for the changes in NOTCH stability and signaling activity during cell-cycle progression, we examined the expression of the full-length LIN-12::GFP and the NICD::GFP reporters as well as the expression of the target gene *lip-1* in different cyclin mutants.

We first examined the influence of the G1-specific D-type cyclin gene *cyd-1* on NOTCH signaling using the reduction-of-function allele *cyd-1(q626)* ([@b59]). Although no VPC cell-cycle arrest was observed, *cyd-1(q626)* mutants displayed reduced levels of LIN-12::GFP in P5.p and P7.p ([Figure 5A](#f5){ref-type="fig"}). Moreover, the expression of the LIN-12 target gene *lip-1* was strongly decreased in the P5.p and P7.p descendants of *cyd-1(q626)* mutants ([Figure 5B](#f5){ref-type="fig"}). Due to the proximity of the *nicd::gfp* integration site to the *cyd-1* locus on LGII, it was not possible to examine NICD::GFP expression in *cyd-1(q626)* animals. However, *cyd-1* RNAi did not cause an obvious reduction in NICD::GFP expression in the VPCs. Rather, in the six cases, in which P6.p was arrested, P6.p continued to express NICD::GFP at high levels similar to the expression pattern observed in *egl-17p::cki-1* animals ([Supplementary Figure S4](#S1){ref-type="supplementary-material"}; [Figure 3C](#f3){ref-type="fig"}).

Furthermore, we tested if the *cyd-1(q626)* mutation modifies the vulval phenotype caused by NICD::GFP expression. For this purpose, we used an extrachromosomal *nicd::gfp* array (*zhEx500*) to score vulval induction in the *cyd-1(q626)* background. The *cyd-1(q626)* mutation significantly decreased vulval induction in animals carrying the *zhEx500\[nicd::gfp\]* array when compared with *cyd-1(+); zhEx500\[nicd::gfp\]* controls ([Table I](#t1){ref-type="table"}, rows 2, 3). Taken together, we conclude that *cyd-1* controls NOTCH signaling at the level of the full-length LIN-12 receptor and possibly also downstream of NICD at the level of target gene expression. Since NOTCH signaling prevents the degradation of full-length LIN-12 ([@b43]; [@b53]), it is possible that the reduced expression of the LIN-12::GFP reporter in *cyd-1(q626)* mutants is caused by a disruption of this positive feedback loop.

We next analyzed the effect of the G1-specific E-type cyclin *cye-1* using the strong reduction-of-function or null allele *ku256* ([@b23]). Expression of the NICD::GFP reporter in homozygous *cye-1(ku256)* mutants was strongly reduced, in both the 1° and the 2° VPCs and their descendants ([Figure 5C](#f5){ref-type="fig"}). Moreover, vulval induction was slightly but significantly suppressed in homozygous *cye-1(ku256); nicd::gfp* mutants when compared with heterozygous *cye-1(ku256)/+; nicd::gfp* controls ([Table I](#t1){ref-type="table"}, rows 4, 5).

Finally, we investigated the influence of the G2-specific B-type cyclins *cyb-1*, *cyb-2*, and *cyb-3* on NICD stability. Since the available deletion mutations in the *cyb* genes cause embryonic or larval lethality, we reduced *cyb* gene activities by RNAi-mediated knockdown. *cyb-2* represents two highly similar and functionally redundant genes, *cyb-2.1* and *cyb-2.2*, that were simultaneously affected by the same RNAi treatment. Only *cyb-3* RNAi caused an increase in NICD::GFP expression ([Figure 5D](#f5){ref-type="fig"}). Even though RNAi against *cyb-3* did not cause a cell-cycle arrest in the VPCs, *cyb-3* RNAi animals exhibited significantly higher NICD::GFP levels in the P6.p descendants at the Pn.px stage compared with control RNAi animals ([Figure 5D](#f5){ref-type="fig"}). We thus conclude that both the G1 cyclins CYD-1 and CYE-1 positively regulate LIN-12 NOTCH signaling. CYD-1 appears to act primarily by regulating full-length LIN-12, while CYE-1 seems to exert a stabilizing effect on the intracellular pool of NICD. On the other hand, CYB-3 may act together with CDK-1 during the late G2 phase to directly or indirectly target NICD for degradation before M-phase entry.

The N-terminal ankyrin and the C-terminal PEST domain regulate NICD stability
-----------------------------------------------------------------------------

To identify the domains necessary for NICD degradation, we performed a structure function analysis. The LIN-12 NICD is composed of a nuclear localization signal (NLS) at the N-terminus followed by the RBP-Jkappa-associated module (RAM) containing the downregulation targeting signal (DTS) motif, which promotes NOTCH endocytosis ([@b53], [@b54]; [@b40]). The central part contains seven ankyrin repeats (ANK) that are essential for the interaction with CSL and other transcription factors and for NICD dimerization. Near its C-terminus, NICD contains a proline/glutamic acid/serine/threonine (PEST) motif that binds to the F-Box protein SEL-10 and regulates protein degradation ([@b33]). We integrated different NICD::GFP deletion constructs as single copy transgenes into the genome via MosSCI, allowing us to compare expression levels between different transgenes ([@b28]). A construct lacking the C-terminus with the PEST domain (NICD::GFPΔCT) showed persistent expression in the P6.p descendants and elevated levels in the P5.p and P7.p descendants ([Figure 6C](#f6){ref-type="fig"}). However, the reciprocal construct harboring just the C-terminal PEST domain (NICD::GFPΔNT) was only partially downregulated in the 1° lineage ([Figure 6D](#f6){ref-type="fig"}). Since the NICD::GFPΔNT signal was detected mainly in the cytoplasm, we examined if nuclear localization was necessary for proper NICD degradation by deleting the seven ANK repeats but leaving the N-terminal 67 amino acids containing the NLS, RAM, and DTS domains in place (NICD::GFPΔANK). Even though the NICD::GFPΔANK protein localized to the nuclei of the VPCs and their descendants, it was not efficiently downregulated in the 1° lineage. Since the deletion of the N-terminal RAM and DTS resulted in the formation of a very unstable protein that was only weakly expressed at the early or mid L2 stage, before NICD is normally degraded, the combination of ANK and PEST domains alone could not be analyzed. Taken together, our structure function analysis indicates that the PEST domain and the ANK repeats together regulate the NICD degradation.

Discussion
==========

We have developed a new state-based computational model for cell fate specification during *C. elegans* vulval development and experimentally tested the predictions made by the model. When using interacting state-machine models to describe a biological behavior, we are facing the question of how to compose the components comprising the model. We previously found that the two standard notions of concurrency, in this context, synchrony and asynchrony, are not appropriate to model the VPC interactions ([@b25]). Synchronous composition is too rigid, making it impossible to break the symmetry between processes without the introduction of additional timing mechanisms. On the other hand, asynchronous composition introduces a difficulty in deciding how long to wait for a signal that may never arrive, again requiring artificial timing mechanisms. We have therefore implemented *bounded asynchrony* in our previous model of VPC specification ([@b26]). This allows the components of a system to move independently with a certain degree of randomness, while keeping them coupled within certain boundaries.

The concept of *bounded asynchrony* may apply particularly well to the case of VPC fate specification in *C. elegans*. First, the progression of VPCs through the cell cycle does indeed occur with a certain degree of variability, as the VPCs enter the M phase in a random order. After a long G1-phase arrest during the L2 larval stage, the VPCs enter S phase at the L2-to-L3 transition ([@b21]) and progress through the remainder of the cell cycle in a more or less synchronized way. Second, cell-cycle progression and signaling events are coupled, as a cell cycle-dependent sequence of 1° and 2° cell fate specification has previously been observed ([@b4]). Our data suggest that the degradation of NICD during the late G2 phase is an additional mechanism used to establish this temporal order in 1° and 2° fate specification.

By arresting the cell cycle of the VPC that normally adopts the 1° cell fate in the G1 phase without affecting the progression of the other VPCs, we could experimentally test the concept of *bounded asynchrony*. Even though 1° fate specification in P6.p occurs already toward the end of the G1 phase ([@b4]), G1-arrested P6.p cells could not adopt a stable 1° cell fate, resulting in the simultaneous expression of 1° and 2° cell fate markers. We traced this instability in fate specification back to a persisting expression of LIN-12 NOTCH in the arrested cells. It has previously been reported that 1° cell fate specification results in the rapid endocytosis of full-length LIN-12 from the apical plasma membrane, a process that depends on Ser/Thr phosphorylation of a cis-acting downregulation (DTS) element in the cytoplasmic portion of LIN-12 ([@b54]). Endocytosis of LIN-12 is followed by rapid degradation in the lysosomes. Interestingly, the LIN-12::GFP protein in G1-arrested VPCs did not remain on the apical cell membrane, where it is normally concentrated in VPCs adopting the 2° cell lineage. Rather, the intracellular LIN-12 cleavage product (NICD) accumulated in the cytoplasm and nucleus. We conclude that the endocytosis and lysosomal degradation of full-length LIN-12 is already occurring during the G1 phase of the cell cycle ([@b4]), or it is not linked to cell-cycle progression at all. We thus postulate the existence of a second LIN-12 NOTCH degradation pathway that is tightly coupled to cell-cycle progression and dedicated to the destruction of NICD in the nucleus ([Figure 7](#f7){ref-type="fig"}). This nuclear NICD degradation pathway is only effective during the G2 phase of the cell cycle.

On the basis of our findings, we propose a model, in which NICD is stabilized and accumulates in the VPCs during the G1 phase thanks to the activity of the CDK-4/CYD-1 and CDK-2/CYE-1 complexes. In analogy to *Drosophila* dacapo, constitutive expression of CKI-1 blocks entry into S phase most likely by inhibiting CDK-2/CYE-1 activity ([@b17]; [@b9]; [@b60]). Similarly to its mammalian homologs, CKI-1 and CDK-4/CYD-1 may form a complex, which sequesters and inhibits CKI-1 and at the same time stabilizes CDK-4/CYD-1 ([@b41]; [@b13]; [@b9]). Therefore, arresting a 1° VPC in the G1 phase by CKI-1 overexpression may increase LIN-12 NOTCH activity due to the persisting activity of CDK-4/CYD-1 and the absence of G2 CDK/Cyclin activity. After the VPCs have completed the S phase, activation of the CDK-1/CYB-3 complex during the late G2 phase may directly or indirectly target NICD for degradation, resulting in the termination of the NOTCH signal in the 1° cell lineage before M-phase entry. The nature of the signals targeting NICD for destruction and causing a higher rate of NICD decay in the 1° than in the 2° lineage remains to be identified. In vertebrate cells, the stability of NICD is negatively regulated by phosphorylation of the PEST domain and deacetylation of the ANK repeats ([@b15]; [@b33]; [@b50]; [@b62]; [@b32]). Accordingly, our *in vivo* structure function analysis indicated that both the ANK repeats and the PEST domain are required for efficient degradation of NICD in the VPCs.

Taken together, these findings point at a temporal sequence of signaling events and a mechanism, by which the coordinated progression of VPCs through the cell cycle allows the formation of a stable cell fate pattern. First, activation of the EGFR/RAS/MAPK pathway by the AC signal during the G1 phase induces the 1° cell fate in P6.p. Still during the G1 phase, LIN-12 NOTCH signaling is activated in the 2° cells as a consequence of high EGFR/RAS/MAPK activity in the 1° cell, which leads to the induction of DSL ligand expression by P6.p ([@b58]; [@b12]). The 1° versus 2° cell fate decision, however, can only be sealed after the G1 arrest has been relieved and NICD has been degraded in the 1° cell lineage during the late G2 phase. Thus, by linking the inactivation of the key cell fate determinant NOTCH to cell-cycle progression, a boundary is created that prevents VPCs from becoming de-synchronized. The heterochronic gene pathway that regulates the G1-to-S checkpoint in the VPCs may represent a biological equivalent of the global 'scheduler\' in the computational model ([@b21]; [@b60]). The early heterochronic genes maintain the expression of the CDK inhibitor CKI-1 during the L2 larval stage. Expression of *cki-1* ceases due to a switch in heterochronic gene expression at the L2-to-L3 transition, thus lifting the boundary and allowing VPCs to enter S phase ([@b35]).

In many cases of cell fate specification, the coordination of different intercellular signaling pathways is critically dependent on spatial and temporal control mechanisms linked to the cell cycle, which determines a cell\'s competence to respond to extrinsic signals ([@b30]; [@b45]; [@b61]). Cell-cycle control of developmental decisions may be particularly important in situations where a cell is sensitive to multiple signals that specify distinct outcomes. Therefore, specific cell fate choices need to be executed with a certain priority or temporal sequence. To link different steps of cell fate determination to specific cell-cycle phases could be a general strategy used to temporally coordinate cell fate choices among equivalent cells. This strategy allows the sequencing and prioritizing of different developmental programs within a single cell lineage. In complex multicellular environments, coupling cell-cycle progression to signal transduction could provide a means to limit the number of cells in a population that can respond to extrinsic signals at a given time point. Thus, the deregulation of the cell cycle observed in many tumor cells may not only affect cell proliferation but also the responsiveness of the cells to growth factors, causing cell fate transformations or de-differentiation. While numerous studies have demonstrated a strong influence of intercellular signaling on cell-cycle progression ([@b10]; [@b14]; [@b63]), fewer studies focused on the impact of the cell cycle on signaling ([@b47]; [@b16]; [@b2]). *Bounded asynchrony* achieved through cell-cycle control of signal transduction could be a global principle utilized during the development of multicellular organisms. Finally, by exploring the various mechanisms linking cell-cycle progression to signaling we will better understand how deregulation of the cell cycle promotes tumor development.

Materials and methods
=====================

Timed automata
--------------

A timed automaton is a mathematical model for describing systems that have discrete states that interact with continuous time. Its behavior consists of discrete changes of states and continuous evolution of time. A given automaton describes the possible sequence of changes in discrete states and their timing. Technically, the automaton has one or more clocks that measure time. These clocks can be reset when the automaton changes its discrete states, and in turn, the automaton uses the clocks to determine how long to stay in states and which discrete state changes are possible. This leads to state sequences (with their timing) to be possible (accepted) in the automaton or impossible (rejected). Events attached to transitions of the automaton can serve as a communication mechanism between multiple timed automata. A system is modeled by creating a timed automaton that produces all the possible behaviors of this system and not more. An example of a timed automaton and an explanation of its possible behaviors are given in [Figure 1B--D](#f1){ref-type="fig"}. We used the tool Uppaal for modeling and analysis of timed automata ([@b42]).

*C. elegans* strains and constructs
-----------------------------------

Standard methods were used for maintaining and manipulating *C. elegans* ([@b64]). The following mutations and transgenes were used: LGI: *cye-1(ku256)* ([@b23]), *ayIs4\[egl-17::gfp\]* ([@b11]), LGII: *zhIs39\[bar-1p::nicd::gfp::unc-54 3′utr, unc-119(+)\]*, *zhIs49\[bar-1p::yfp::unc-54 3′utr, unc-119(+)\], zhIs56\[bar-1p::nicd::gfp*Δ*CT::unc-54 3′utr, unc-119(+)\], zhIs50.1\[bar-1p::nicd::gfp*Δ*NT::unc-54 3′utr, unc-119(+)\], zhIs55\[bar-1p::nicd::gfp*Δ*ANK::unc-54 3-1p::nicd::gfp+)\], mfIs41\[lip-1::yfp, myo-2::rfp\]* (gift of Marie-Anne Felix), *cyd-1(q626)* ([@b59])*, unc-4(e120)*, LGIII: *unc-119(ed3*), *zhIs4\[lip-1::gfp\]* ([@b7]), LGIV: *dpy-20(e1282)*, LGV: *arIs92\[egl-17::cfp, tax-3::gfp\]*, *arIs82\[*LIN-12::GFP*; unc-4(*+*); egl-17p::LacZ\]* ([@b53]), Balancer chromosome: *+/hT2\[dpy-18(h662)\]; +/hT2\[bli-4(e937)\]* (I;III), extrachromosomal arrays: *zhEx314, zhEx315\[egl-17p::cki-1, lin-48::gfp\], zhEx334, zhEx367\[egl-17p::cki-1, myo-2::mcherry\], zhEx500\[bar-1p::nicd::gfp::unc-54 3′utr, unc-119(+); myo-2p::mCherry\]*.

Plasmid constructs
------------------

GFP reporter constructs had been made by gateway cloning (MultiSite Gateway® Three-Fragment Vector Construction Kit; Invitrogen) using PCFJ150 as final destination vector. The reporter constructs were inserted as single copies into the *C. elegans* genome using MosSCI ([@b28]). The entry vectors listed in [Supplementary Table 2](#S1){ref-type="supplementary-material"} were sub-cloned using the listed primers and genomic DNA as template, unless otherwise stated.

Additional plasmids used were pVT363(*egl-17p::cki-1*) ([@b35]), pTJ1157(*lin-48p::gfp*) ([@b65]), backbone plasmids and plasmids containing co-injection markers for MosSCI ([@b28]).

Germline transformation
-----------------------

Worms were transformed by microinjection as described ([@b46]).

Plasmids were injected at a concentration of 50 ng/μg together with the co-injection marker pTJ1157 (50 ng/μg) or pCFJ90 (2.5 ng/μg).

To integrate single copies of transgenes, the MosSCI method was used as described ([@b28]).

Time-course experiment
----------------------

Eggs were obtained by bleaching adult animals for 10 min in 1 ml 400 mM NaOH, 7% sodium hypochlorite followed by three washing steps with M9 or water. The eggs were allowed to hatch on an NGM plates without food. To obtain a highly synchronized population of larvae, all the L1 larvae that hatched during a 30-min interval were collected by mouth pipetting, placed on growth plates with food and cultivated at 20°C. After 24 h about 20 worms were analyzed every 30 min until the VPCs had divided. Due to the limited number of larvae that could be collected over a single 30-min time period, the time-course experiment shown in [Figure 3](#f3){ref-type="fig"} was done in batches over three different days (first day: 24--27 h; second day: 27.5--28.5 h; third day: 30--36 h).

S-phase arrest
--------------

Eggs obtained by bleaching (see above) were allowed to hatch in M9 medium overnight without food. After transferring the L1 larvae to NGM plates with food, they were cultivated at 20°C for 28 h, when early L3 larvae were placed for 14 h on NGM plates containing 40 mM hydroxyurea with food. Control animals remained on NGM plates without hydroxyurea.

RNAi experiments
----------------

For RNA interference, the feeding method described by [@b38] was used. The worms were synchronized by bleaching (see time-course experiment). L1 larvae were placed on growth media plates containing 3 mM IPTG, 50 μg/ml ampicillin and 50 μg/ml tetracycline and bacteria of specific RNAi strains. Worms were allowed to grow for 36 h at 20°C and analyzed.

*C. elegans* microscopy and image analysis
------------------------------------------

Animals of the indicated stages (Pn.p, Pn.px, or Pn.pxx) were placed in 4 μl of 5 mM tetramisole solution in M9 on 4% agarose pads. Fluorescent images were acquired on a Leica DMRA wide-field microscope equipped with a cooled CCD camera (Hamamatsu Orca ER) controlled by the Openlab 5 software package (Improvision). For quantification of GFP intensity, images were acquired with the same microscope, camera and software settings using GFP-specific filter sets. The intensity of GFP expression was measured using the measurement tool in the Openlab software. Each measurement was standardized to the background intensity in the same animal (GFP intensity in arbitrary units). Microsoft Excel (Version 11.5.3) and an R 2.11.1 script were used for data processing and statistical analysis. Data were analyzed by the bootstrap method (10 000 bootstrap samples). The standard errors of the samples were estimated by the bootstrap method ([@b18]). The significance levels \*\*\**P*\<0.001, \*\**P*\<0.01, and \**P*\<0.05 were determined by calculating the *P*-value for the differences between two samples and corrected for multiple testing according to Bonferroni.
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![A model for *bounded asynchrony* during VPC differentiation. (**A**) Intercellular signals determining the VPC fates. The AC signal induces the 1° fate in P6.p. P6.p then inhibits its neighbors P5.p and P7.p via lateral LIN-12 NOTCH signaling from adopting the 1° fate and induces the 2° fate. (**B**) An example illustrating the concept of timed automata. This automaton outputs possible sequences of a, b, and c events. The automaton starts in state S1 from where it can transit to state S2, signaling this with event a. After this transition, the automaton starts measuring time by setting clock *x* to 0. Then, the transition from S2 to S3 (with output event b) has to occur \<1 time unit after a, and the transition from S3 back to S1 (with output event c) has to occur at least 2 time units after a. Overall, the observable communication events are rounds of a, b, and c events, where b is \<1 time unit after a and c is at least 2 time units after a. There is no restriction on the time of the next a. (**C**) A timed automaton modeling an independent scheduler. A run starts in the state start and sets the clock *x* to 0. The automaton can perform an action between time *t*−1 and time *t*+1, and once it performs the action starts counting time again to the next action. Possible behaviors include sequences of actions where the time between every two actions is between *t*−1 and *t*+1. Running an independent copy of this automaton in each VPC gives rise to bounded asynchrony. (**D**) Random simulation of four copies of the timed automaton shown in (C) running in parallel. Every automaton moves between 9 and 11 time units. The first point where one process makes two actions more than another process is after 120 time units where a3 action was performed 12 times and a4 actions only 10 times (arrow and magnification). The earliest time point where such a difference is theoretically possible is after 99 time units, when a process moving very fast could perform 11 actions and a process moving very slowly could perform 9 actions. (**E**) The 1° and 2° VPCs divide asynchronously without a significant bias for one VPC entering M phase before the others. VPC divisions were observed in wild-type (gray bars) and *nicd::gfp* (white bars, see below) animals. The panels to the right show three examples of asynchronous VPC divisions where the brackets indicate the dividing VPC and the arrowheads the undivided VPCs. Error bars indicate the standard error as described in Materials and methods. The scale bar represents 10 μm. Source data is available for this figure in the [Supplementary Information](#S1){ref-type="supplementary-material"}.](msb201251-f1){#f1}

![Degradation of LIN-12 NOTCH is blocked in G1-arrested P6.p. (**A**) Expression of the 2° fate marker *lip-1p::gfp* persists in the G1-arrested P6.p cell of an *egl-17p::cki-1* transgenic animal (arrowheads in the right panels), while *lip-1p::gfp* expression is downregulated in the P6.p descendants of a sibling that had lost the *egl-17p::cki-1* array (brackets in the left panels). (**B**) LIN-12::GFP persists in the G1-arrested P6.p cell of an *egl-17p::cki-1* transgenic animal (arrowheads in the right panels), while LIN-12::GFP is efficiently degraded in the P6.p descendants of a sibling that had lost the *egl-17p::cki-1* array (brackets in the left panels). Note the accumulation of the GFP signal in the nucleus and cytoplasm of the arrested P6.p cell. Black asterisks denote uterine LIN-12::GFP expression. In all panels, the corresponding Nomarski images are shown on top. The scale bars represent 10 μm. Quantifications of *lip-1p::gfp* and intracellular LIN-12::GFP expression are shown to the right. Error bars indicate the standard error and asterisks indicate the significance as described in Materials and methods. Source data is available for this figure in the [Supplementary Information](#S1){ref-type="supplementary-material"}.](msb201251-f2){#f2}

![Time-course analysis of NICD degradation. (**A**) NICD::GFP levels in P5.p, P6.p, and P7.p were measured every half an hour in around 20 synchronized animals at each time point (left scale). The time is indicated in hours after hatching (see Materials and methods). Error bars indicate the standard errors and asterisks significant differences between 1° and 2° lineages as described in Materials and methods. The percentage of animals with at least one proximal VPC division is indicated by the black line (right scale). (**B**) Representative pictures of NICD::GFP expression in an early L2 (+25 h, Pn.p stage), a late L2 (+33 h, Pn.p stage), and an early L3 (+36 h, Pn.px stage) larva. Note the uniform NICD::GFP expression in the VPCs at +25 h and the downregulation in P6.p at +33 h (arrowheads) and in P6.px at +36 h (bracket). (**C**) NICD::GFP persists in the G1-arrested P6.p cell of an *egl-17p::cki-1* transgenic animal (arrowheads in the right panels), whereas NICD::GFP is downregulated in the P6.p descendants of a sibling that had lost the *egl-17p::cki-1* array (brackets in the left panels). In all panels, the corresponding Nomarski images are shown on top. The scale bars represent 10 μm. A quantification of NICD::GFP expression is shown to the right. Error bars indicate the standard error and asterisks indicate the significance as described in Materials and methods. Source data is available for this figure in the [Supplementary Information](#S1){ref-type="supplementary-material"}.](msb201251-f3){#f3}

![NICD is degraded during the G2 phase. (**A**) Expression of the 2° fate marker *lip-1p::yfp* persists in P6.p of a hydroxyurea (HU)-treated larva (arrowheads in the right panels), while expression is downregulated in an untreated control animal at the Pn.p stage (arrowheads in the left panels). (**B**) NICD::GFP persists in the undivided P6.p cell of a hydroxyurea-treated larva (arrowheads in the right panels), but NICD::GFP is downregulated in the P6.p descendants of an untreated control larva at the Pn.px stage (brackets in the left panels). (**C**) NICD::GFP persists in the G2-arrested P6.p cell of a *cdk-1* RNAi-treated animal at the Pn.px stage (arrowheads in the right panels), while NICD::GFP is downregulated in the P6.p descendants of an empty vector RNAi-treated control animal (brackets in the left panels). Note that due to the incomplete penetrance of the *cdk-1* RNAi effect, only P6.p had arrested in the example shown in the right panels. In all panels, the corresponding Nomarski images are shown on top. The scale bars represent 10 μm. Quantifications of *lip-1p::yfp* and NICD::GFP expression are shown to the right. Error bars indicate the standard error and asterisks indicate the significance as described in Materials and methods. Source data is available for this figure in the [Supplementary Information](#S1){ref-type="supplementary-material"}.](msb201251-f4){#f4}

![Differential regulation of NOTCH signaling by G1 and G2 cyclins. (**A**) Localization of LIN-12::GFP to the apical plasma membrane is diminished in the VPC descendants in *cyd-1(q626)* mutants (right panels) when compared with wild-type controls (left panels). Black asterisks denote uterine LIN-12::GFP expression. (**B**) Expression of the 2° fate marker *lip-1p::gfp* is reduced in the P5.p and P7.p descendants in *cyd-1(q626)* mutants (right panels) compared with wild-type controls (left panels). (**C**) NICD::GFP expression is reduced in the VPC descendants in homozygous *cye-1(ku256)* mutants (right panels) when compared with heterozygous *cye-1(ku256)/+* controls (left panels). (**D**) NICD::GFP expression persists in the P6.p descendants of a *cyb-3* RNAi-treated animal at the Pn.px stage (brackets in the right panels). Note that in contrast to *cdk-1* ([Figure 4C](#f4){ref-type="fig"}), *cyb-3* RNAi did not induce a cell-cycle arrest. An empty vector RNAi-treated control animal is shown in the left panels. In all panels, the corresponding Nomarski images are shown on top. The scale bars represent 10 μm. Quantifications of LIN-12::GFP, *lip-1p::gfp* and NICD::GFP expression are shown to the right. Error bars indicate the standard error and asterisks indicate the significance as described in Materials and methods. Source data is available for this figure in the [Supplementary Information](#S1){ref-type="supplementary-material"}](msb201251-f5){#f5}

![Identification of the domains regulating NICD protein stability. (**A**) Expression pattern of the YFP::LacZ as control, (**B**) the complete LIN-12 intracellular domain (NICD::GFP), (**C**) a C-terminal truncation of 87 amino acids containing the PEST domain (NICD::GFPΔCT), (**D**) an N-terminal deletion of 384 amino acids removing the RAM domain and ANK repeats (NICD::GFPΔNT), and (**E**) an internal deletion of 324 amino acids removing the ANK repeats (NICD::GFPΔANK). All constructs were expressed using the VPC-specific *bar-1* promoter fragment ([@b49]) and inserted via MosSCI as single copy transgenes at the same location on LGII. Expression was scored in the descendants of P5.p, P6.p, and P7.p at the Pn.px stage. For each construct, a quantification of the GFP levels is shown in the bar graphs in the center. Error bars indicate the standard error as described in Materials and methods. Representative animals for each construct are shown in the right panels. The brackets indicate the position of the P6.p descendants. The scale bar represents 10 μm. Source data is available for this figure in the [Supplementary Information](#S1){ref-type="supplementary-material"}.](msb201251-f6){#f6}

![Model for cell-cycle regulation of LIN-12 NOTCH signaling. During the G1 phase of the cell cycle, LIN-12 NOTCH is cleaved upon binding to a DSL ligand, thereby releasing the NICD fragment that activates transcription of target genes. Alternatively, NOTCH can undergo endocytosis followed by lysosomal degradation. The activity of the G1-specific CDK-4/CYD-1 and CDK-2/CYE-1 complexes positively regulate LIN-12 NOTCH signaling in P5.p, P6.p, and P7.p by stabilizing full-length NOTCH at the apical plasma membrane and NICD in the nucleus, respectively. Degradation of NICD in P6.p occurs during the G2 phase, when activation of the G2-specific CDK-1/CYB-3 complex terminates NOTCH signaling by inducing ubiquitin-mediated proteasomal degradation of NICD.](msb201251-f7){#f7}

###### Positive regulation of NOTCH signaling by G1 cyclins

  Row   Genotype                                Induction±s.e.      *n*
  ----- --------------------------------------- ------------------- -----
  1     *zhIs039\[nicd::gfp\]*                  5.85±0.04           36
  2     *zhEx500\[nicd::gfp\]*                  5.27±0.12\]\*\*\*   34
  3     *cyd-1(q626)*; *zhEx500\[nicd::gfp\]*   4.63±0.14           36
  4     *cye-1(ku256)/+; zhIs39\[nicd::gfp\]*   5.96±0.03\]\*\*\*   56
  5     *cye-1(ku256); zhIs39\[nicd::gfp\]*     5.52±0.09           30

Induction indicates the average number of induced VPCs (1° or 2° fate) per animal and s.e. the standard error determined by bootstrapping (see Materials and methods). \*\*\*Indicates a significance of *P*\<0.001 and *n* the number of animals scored for each genotype. For *cye-1(ku256)*, the homozygous mutants were compared with their heterozygous siblings on the same plates. Source data is available for this table in the Supplementary Information.
